Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

BioRestorative Therapies (9OF0) Stock Price & Analysis

1 Followers

9OF0 Stock Chart & Stats

€0.13€0.00(0.00%)
At close: 5:30 PM GMT+1
€0.2€0.3Jun 25Jul 24Sep 3
Day’s Range
EUR 0.12 - EUR 0.13
52-Week Range
EUR 0.12 - EUR 1.19
Previous Close
EUR 0.13
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 1.89M
Enterprise Value
EUR 1.27M
Total Cash (Recent Filing)
EUR 3.59M
Total Debt (Recent Filing)
EUR 34.52K
Price to Earnings (P/E)
―
Beta
0.46
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Minimal Leverage

Effectively no debt limits interest expense and reduces direct refinancing pressure while the company funds research and clinical development. This gives management more financial flexibility than a similarly unprofitable biotech carrying significant leverage, although it does not eliminate external funding needs.

Gross Margin Potential

A solid reported gross margin indicates that revenue generated by the current business has economically attractive contribution potential before operating expenses. If BioRestorative expands successful products or therapies, this margin profile could provide a foundation for improved operating leverage, though scale is not yet established.

Governance Strengthening

Adding an independent director with capital-markets experience and committee responsibilities strengthens formal oversight during a period of leadership transition. Reconstituted governance can improve accountability, support more disciplined decisions, and help the company address compliance and financing challenges over the coming quarters.

Bears Say

Shrinking Revenue And Losses

The very small and declining revenue base is not supporting the company’s operating cost structure, leaving profitability far from breakeven. A net margin near negative 3,090% indicates that meaningful commercialization or substantial expense reduction is needed before the business can generate durable earnings.

Persistent Cash Burn

Sustained operating and free-cash-flow deficits show that the company consumes substantial cash while developing its pipeline and cannot currently fund operations from internally generated resources. Continued reliance on external funding may constrain strategic flexibility and create recurring financing pressure.

Nasdaq Compliance Risk

Failure to file a required quarterly report introduces a structural compliance burden and could ultimately threaten continued Nasdaq listing if the company cannot regain compliance. The issue also signals operational strain in financial reporting, potentially complicating access to capital and stakeholder confidence.

BioRestorative Therapies News

9OF0 FAQ

What was BioRestorative Therapies’s price range in the past 12 months?
BioRestorative Therapies lowest stock price was €0.12 and its highest was €1.19 in the past 12 months.
What is BioRestorative Therapies’s market cap?
BioRestorative Therapies’s market cap is €1.89M.
When is BioRestorative Therapies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is BioRestorative Therapies overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BioRestorative Therapies pay dividends?
BioRestorative Therapies does not currently pay dividends.
What is BioRestorative Therapies’s EPS estimate?
BioRestorative Therapies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioRestorative Therapies have?
BioRestorative Therapies has 1,381,128 shares outstanding.
Which hedge fund is a major shareholder of BioRestorative Therapies?
Currently, no hedge funds are holding shares in DE:9OF0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology